Purple Biotech Ltd
PPBT
$3.95
$0.102.55%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 12.32% | -19.92% | -44.69% | -60.83% | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | -43.64% | -- | 34.15% | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | 25.69% | -16.70% | -36.26% | 0.63% | |
| Total Current Assets | 10.75% | -19.72% | -43.58% | -58.50% | |
|
|
|||||
| Total Current Assets | 10.75% | -19.72% | -43.58% | -58.50% | |
| Net Property, Plant & Equipment | 20.14% | -37.88% | -38.72% | -36.27% | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -73.57% | 0.00% | -0.72% | -0.72% | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | -- | -- | -- | -- | |
| Total Assets | -52.56% | -4.68% | -16.40% | -22.46% | |
|
|
|||||
| Total Accounts Payable | 42.27% | -78.01% | -58.81% | -26.26% | |
| Total Accrued Expenses | 14.42% | -46.39% | -65.35% | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 33.33% | -43.41% | -2.66% | 3.37% | |
| Total Finance Division Other Current Liabilities | 253.87% | -75.71% | -54.37% | -2.49% | |
| Total Other Current Liabilities | 253.87% | -75.71% | -54.37% | -2.49% | |
| Total Current Liabilities | 94.46% | -66.16% | -58.90% | -12.23% | |
|
|
|||||
| Total Current Liabilities | 94.46% | -66.16% | -58.90% | -12.23% | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -80.21% | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | 14.29% | -0.71% | -0.71% | 0.00% | |
| Total Liabilities | 91.74% | -65.18% | -58.75% | -13.96% | |
|
|
|||||
| Common Stock & APIC | 3.29% | 10.49% | 10.85% | 7.99% | |
| Retained Earnings | -18.24% | -1.82% | -5.27% | -8.79% | |
| Treasury Stock & Other | -5.39% | -23.91% | -22.23% | -21.34% | |
| Total Common Equity | -70.44% | 9.17% | -3.94% | -23.80% | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | -70.44% | 9.17% | -3.94% | -23.80% | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -207.84% | -27.87% | -43.33% | -53.72% | |
| Total Equity | -70.65% | 9.10% | -4.04% | -23.90% | |
|
|
|||||